Stay updated on Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial page.

Latest updates to the Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial page
- Check7 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed study information regarding a Phase II trial for MMR-proficient colorectal cancer and the addition of a new revision number and collaborators.SummaryDifference45%
- Check15 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check58 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check73 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check80 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.1%
Stay in the know with updates to Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial page.